First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non–Small-cell Lung Cancer: Quality of Life Results From a Randomized Phase III Trial

Title

First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non–Small-cell Lung Cancer: Quality of Life Results From a Randomized Phase III Trial

Authors

Keywords

Adenocarcinoma, Chemotherapy, Epidermal growth factor receptor tyrosine kinase inhibitor, Patient-reported outcomes, Phase III

Journal

Clinical Lung Cancer

Volume 17, Issue 2, Pages 150-160

Publisher

Elsevier BV

Online

2015-12-19

DOI

10.1016/j.cllc.2015.12.004